Company Enumeral Biomedical Holdings Inc
Equities
ENUM
US2940171083
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kevin G. Sarney
PSD | President | 59 | 14-07-30 |
Matthew A. Ebert
SEC | Corporate Secretary | - | 13-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kevin G. Sarney
PSD | President | 59 | 14-07-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 128,409,788 | 107,089,884 ( 83.40 %) | 0 | 83.40 % |
Company contact information
Enumeral Biomedical Holdings, Inc.
1337 Massachusetts Avenue Suite 243
02476, Arlington
+
Sector
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ENUM Stock
- Company Enumeral Biomedical Holdings Inc